Q3 2024 Earnings Call Transcript November 6, 2024 UroGen Pharma Ltd. beats earnings expectations. Reported EPS is $-0.55, expectations were $-0.82. Operator: Good morning, ladies and gentlemen. Thank ...
Based on these results, we initiated our first global randomized Phase 3 ... activities, all of which are critical path to the program, that we could also obtain regulatory alignment on the study ...
Japan 10 Year Government Bond 0.0050 1.0059% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback